These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21422845)

  • 1. Oral contraceptives and heavy periods.
    Drife JO
    Obstet Gynecol; 2011 Apr; 117(4):773-774. PubMed ID: 21422845
    [No Abstract]   [Full Text] [Related]  

  • 2. Improving the objective quality of large-scale clinical trials for women with heavy menstrual bleeding: experience from 2 multi-center, randomized trials.
    Fraser IS; Zeun S; Parke S; Wilke B; Junge W; Serrani M
    Reprod Sci; 2013 Jul; 20(7):745-54. PubMed ID: 23439617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial.
    Jensen JT; Parke S; Mellinger U; Machlitt A; Fraser IS
    Obstet Gynecol; 2011 Apr; 117(4):777-787. PubMed ID: 21422847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Estradiol Valerate/Dienogest for the Management of Heavy Menstrual Bleeding: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase III Clinical Trial.
    Yu Q; Zhou Y; Suturina L; Jaisamrarn U; Lu D; Parke S
    J Womens Health (Larchmt); 2018 Oct; 27(10):1225-1232. PubMed ID: 29957101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of heavy menstrual bleeding with the estradiol valerate and dienogest oral contraceptive pill.
    Micks EA; Jensen JT
    Adv Ther; 2013 Jan; 30(1):1-13. PubMed ID: 23239397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normalization of blood loss in women with heavy menstrual bleeding treated with an oral contraceptive containing estradiol valerate/dienogest.
    Fraser IS; Jensen J; Schaefers M; Mellinger U; Parke S; Serrani M
    Contraception; 2012 Aug; 86(2):96-101. PubMed ID: 22240178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estradiol valerate and dienogest: a novel four-phasic oral contraceptive pill effective for pregnancy prevention and treatment of heavy menstrual bleeding.
    Micks E; Jensen JT
    Womens Health (Lond); 2011 Sep; 7(5):513-24. PubMed ID: 21879819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on new orally administered contraceptives for women.
    Nelson AL
    Expert Opin Pharmacother; 2015; 16(18):2759-72. PubMed ID: 26512437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective treatment of heavy and/or prolonged menstrual bleeding with an oral contraceptive containing estradiol valerate and dienogest: a randomized, double-blind Phase III trial.
    Fraser IS; Römer T; Parke S; Zeun S; Mellinger U; Machlitt A; Jensen JT
    Hum Reprod; 2011 Oct; 26(10):2698-708. PubMed ID: 21784734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hormone use in migraine].
    Breckwoldt M
    Dtsch Med Wochenschr; 2003 Aug; 128(33):1731. PubMed ID: 12920674
    [No Abstract]   [Full Text] [Related]  

  • 11. Natazia--a new oral contraceptive.
    Med Lett Drugs Ther; 2010 Sep; 52(1346):71-2. PubMed ID: 20814403
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-effectiveness analysis in the treatment of heavy menstrual bleeding in Spain.
    Calaf J; Lete I; Canals I; Crespo C; Espinós B; Cristóbal I
    Eur J Obstet Gynecol Reprod Biol; 2015 Jan; 184():24-31. PubMed ID: 25462215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest.
    Jensen JT
    Expert Opin Pharmacother; 2010 May; 11(7):1147-57. PubMed ID: 20367275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of four different oral contraceptives on various sex hormones and serum-binding globulins.
    Wiegratz I; Kutschera E; Lee JH; Moore C; Mellinger U; Winkler UH; Kuhl H
    Contraception; 2003 Jan; 67(1):25-32. PubMed ID: 12521654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of estradiol valerate/dienogest on work productivity and activities of daily living in women with heavy menstrual bleeding.
    Wasiak R; Filonenko A; Vanness DJ; Law A; Jeddi M; Wittrup-Jensen KU; Stull DE; Siak S; Jensen JT
    J Womens Health (Larchmt); 2013 Apr; 22(4):378-84. PubMed ID: 23586801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to APC and SHBG levels during use of a four-phasic oral contraceptive containing dienogest and estradiol valerate: a randomized controlled trial.
    Raps M; Rosendaal F; Ballieux B; Rosing J; Thomassen S; Helmerhorst F; van Vliet H
    J Thromb Haemost; 2013 May; 11(5):855-61. PubMed ID: 23410231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of ovarian function by an oral contraceptive containing 30 micrograms ethinyl estradiol in combination with 2.00 mg dienogest.
    Spona J; Feichtinger W; Kindermann C; Moore C; Mellinger U; Walter F; Gräser T
    Contraception; 1997 Sep; 56(3):185-91. PubMed ID: 9347211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of postmenopausal hormone replacement therapy and oral contraceptives on the endogenous estradiol metabolism.
    Mueck AO; Seeger H; Gräser T; Oettel M; Lippert TH
    Horm Metab Res; 2001 Dec; 33(12):744-7. PubMed ID: 11753761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estradiol valerate/dienogest: a novel oral contraceptive.
    Whalen KL; Rose R
    Ann Pharmacother; 2011 Oct; 45(10):1256-61. PubMed ID: 21917554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in skin topography during hormone therapy.
    Kaatz M; Elsner P; Koehler MJ
    Menopause; 2008; 15(6):1193-4. PubMed ID: 18725866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.